Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis

Infection and Immunity

Volumn 75, Issue 3, 2007, Pages 1137-1143

  Hernandez, Julio ^a   Lackner, Andrew ^b   Aye, Pyone ^b   Mukherjee, Kakali ^a   Tweardy, David J ^a   Mastrangelo, Mary Ann ^a   Weinstock, Joel ^c   Griffiths, Jeffrey ^c   D'Souza, Melinda ^a   Dixit, Shantu ^a   Robinson, Prema ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; APREPITANT; CHLORIDE ION; GLUCOSE; MESSENGER RNA; NEUROPEPTIDE; NEUROTRANSMITTER; SUBSTANCE P; SUBSTANCE P ANTAGONIST; SUBSTANCE P RECEPTOR;

AIDS PATIENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; GASTROINTESTINAL TRACT; GENE EXPRESSION; GLUCOSE ABSORPTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST PATHOGEN INTERACTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; JEJUNUM; MACACA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; TECHNIQUE;

ANIMALS; CHLORIDES; CRYPTOSPORIDIOSIS; GLUCOSE; JEJUNAL DISEASES; MACACA; MALABSORPTION SYNDROMES; MONKEY DISEASES; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 33847749421     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01738-05     Document Type: Article

References (39)

1. Abe, Y., N. A. Bui-Thanh, C. M. Ballantyne, and A. R. Burns. 2005. Extra domain A and type III connecting segment of fibronectin in assembly and cleavage. Biochem. Biophys. Res. Commun. 338:1640-1647.
2. Anton, P. A., and F. Shanahan. 1998. Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside"? Ann. N. Y. Acad. Sci. 840:723-734.
3. Argyropoulos, S. V., and D. J. Nutt. 2000. Substance P antagonists: novel agents in the treatment of depression. Expert Opin. Investig. Drugs 9:1871-1875.
4. Berczi, I., I. M. Chalmers, E. Nagy, and R. J. Warrington. 1996. The immune effects of neuropeptides. Baillieres Clin. Rheumatol. 10(2):227-257.
5. Bernstein, C. N., M. E. Robert, and V. E. Eysselein. 1993. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am. J. Gastroenterol. 88:908-913.
6. Bleiberg, H. 2000. A new class of antiemetics: the NK-1 receptor antagonists. Curr. Opin. Oncol. 12:284-288.
7. Blum, A. M., M. A. G. Cook, R. C. Mathew, D. Elliott, and J. V. Weinstock. 1993. Substance P modulates antigen-induced, IFN-gamma production in murine Schistosomiasis mansoni. J. Immunol. 151:225-233.
8. Chu, H. W., M. Kraft, J. E. Krause, M. D. Rex, and R. J. Martin. 2000. Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin. Immunol. 106:713-722.
9. Farthing, M. 2000. Clinical aspects of human cryptosporidiosis. Contrib. Microbiol. 6:50-74.
10. Genta, R. M., C. L. Chappell, A. C. White, Jr., K. T. Kimball, and R. W. Goodgame. 1993. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 105:1769- 1775.
11. Goldin, E., F. Karmeli, Z. Selinger, and D. Rachmilewitz. 1989. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig. Dis. Sci. 34:754-757.
12. Goodgame, R. W., K. Kimball, C. N. Ou, A. C. White, Jr., R. M. Genta, C. H. Lifschitz, and C. L. Chappell. 1995. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 108:1075-1082.
13. Gordon, D., L. S. Ostlere, and C. A. Holden. 1997. Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls. Br. J. Dermatol. 137:921-927.
14. Harp, J. A., W. Chen, and A. G. Harmsen. 1992. Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: the importance of intestinal microflora. Infect. Immun. 60:3509-3512.
15. Joos, G. F., and R. A. Pauwels. 2000. Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases? Trends Pharmacol. Sci. 21:131-133.
16. Juranek, D. D. 1995. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin. Infect. Dis. 21(Suppl. 1):S57-S61.
17. Kandil, H. M., H. M. Berschneider, and R. A. Argenzio. 1994. Tumour necrosis factor alpha changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 35:934-940.
18. Kapel, N., J. F. Huneau, D. Magne, D. Tome, and J. G. Gobert. 1997. Cryptosporidiosis-induced impairment of ion transport and Na+-glucose absorption in adult immunocompromised mice. J. Infect. Dis. 176:834-837.
19. Kelly, P., A. V. Thillainayagam, J. Smithson, J. B. Hunt, A. Forbes, B. G. Gazzard, and M. J. Farthing. 1996. Jejunal water and electrolyte transport in human cryptosporidiosis. Dig. Dis. Sci. 41:2095-2099.
20. Keusch, G. T., D. Hamer, A. Joe, M. Kelley, J. Griffiths, and H. Ward. 1995. Cryptosporidia-who is at risk? Schweiz. Med. Wochenschr. 125:899-908.
21. Lai, J. P., S. D. Douglas, E. Rappaport, J. M. Wu, and W. Z. Ho. 1998. Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J. Neuroimmunol. 91:121-128.
22. Lambrecht, B. N., P. R. Germonpre, E. G. Everaert, I. Carro-Muino, M. De Veerman, C. de Felipe, S. P. Hunt, K. Thielemans, G. F. Joos, and R. A. Pauwels. 1999. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur. J. Immunol. 29:3815-3825.
23. Lieb, K., Y. Treffurth, M. Berger, and B. L. Fiebich. 2002. Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists? Neuropsychobiology 45:2-6.
24. Liu, H., Y. Cao, A. I. Basbaum, A. M. Mazarati, R. Sankar, and C. G. Wasterlain. 1999. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. Proc. Natl. Acad. Sci. USA 96:12096-12101.
25. Madara, J. L., and J. Stafford. 1989. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Investig. 83:724-727.
26. Maunder, R. 2000. Mediators of stress effects in inflammatory bowel disease: not the usual suspects. J. Psychosom. Res. 48:569-577.
27. May, A., and P. J. Goadsby. 2001. Substance P receptor antagonists in the therapy of migraine. Expert Opin. Investig. Drugs 10:673-678.
28. Mazumdar, S., and K. M. Das. 1992. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am. J. Gastroenterol. 87:176-181.
29. Metwali, A., A. M. Blum, L. Ferraris, J. S. Klein, C. Fiocchi, and J. V. Weinstock. 1994. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J. Neuroimmunol. 52:69-78.
30. Moore, R., S. Tzipori, J. K. Griffiths, K. Johnson, L. De Montigny, and I. Lomakina. 1995. Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology 108:1030-1039.
31. Okhuysen, P., C. L. Chappell, J. H. Crabb, C. R. Sterling, and H. L. DuPont. 1999. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180:1275-1281.
32. Ono, M., B. Yu, E. G. Hardison, M. A. Mastrangelo, and D. J. Tweardy. 2004. Increased susceptibility to liver injury after hemorrhagic shock in rats chronically fed ethanol: role of nuclear factor-kappa B, interleukin-6, and granulocyte colony-stimulating factor. Shock 21:519-525.
33. Rameshwar, P., and P. Gascon. 1995. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86:482-490.
34. Riegler, M., I. Castagliuolo, P. T. So, M. Lotz, C. Wang, M. Wlk, T. Sogukoglu, E. Cosentini, G. Bischof, G. Hamilton, B. Teleky, E. Wenzl, J. B. Matthews, and C. Pothoulakis. 1999. Effects of substance P on human colonic mucosa in vitro. Am. J. Physiol. 276:01473-1483.
35. Robinson, P., P. C. Okhuysen, C. L. Chappell, J. V. Weinstock, D. E. Lewis, J. K. Actor, and A. C. White, Jr. 2003. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J. Infect. Dis. 188:290-296.
36. Rupniak, N. M., and M. S. Kramer. 1999. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol. Sci. 20:485-490.
37. Ryu, S. Y., K. S. Jeong, W. K. Yoon, S. J. Park, B. N. Kang, S. H. Kim, B. K. Park, and S. W. Cho. 2000. Somatostatin and substance P induced in vivo by lipopolysaccharide and in peritoneal macrophages stimulated with lipopolysaccharide or interferon-gamma have differential effects on murine cytokine production. Neuroimmunomodulation 8:25-30.
38. Stockmann, M., H. Schmitz, M. Fromm, W. Schmidt, K. Rokos, G. Pauli, P. Scholz, E. O. Riecken, and J. D. Schulzke. 1998. The mechanism of diarrhea in HIV is based on an impaired epithelial barrier function that could be induced by a specific cytokine pattern. Ann. N. Y. Acad. Sci. 859:267-270.
39. Zachrisson, O., N. Lindefors, and S. Brene. 1998. A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Brain Res. Mol. Brain Res. 60:291-295.